MARKET EYE-India's Cipla surges to record high on earnings

Tue Nov 6, 2012 10:23am IST

Related Topics

Stocks

   

* Shares in Cipla gains as much as 4.06 percent to a
record high after the drug maker reported a bigger-than-expected
62 percent surge in July-September net profit. 
* Despite the surge in share prices, Citigroup says on Tuesday
it remains cautious, saying the earnings surprise were mainly
driven by the generic version of anti-depressant drug Lexapro,
whose exclusivity would tail off in the second half of the
fiscal year.
* Cipla had earlier given a revenue guidance of up to 12 percent
 for the current fiscal year, but Citigroup says the company
management has now revised its topline growth to 15 percent or
above in FY13.     
* Citigroup adds positives such as better product mix and upside
from a weaker rupee appeared factored into estimates
and valuations. 
* The bank raised its target price to 390 rupees from 360
rupees, but retained its 'neutral' rating.
* Cipla shares advanced 2.8 percent to 390.90 rupees as of 0437
GMT

 (manoj.dharra@thomsonreuters.com)
FILED UNDER:

Reuters Showcase

Adani Restructuring

Adani Restructuring

Adani says to restructure business  Full Article 

Coal India Stake

Coal India Stake

Coal India 10 pct stake sale fully covered  Full Article 

Trading Fees

Trading Fees

BSE slashes fees in FX derivatives battle with NSE  Full Article 

SpiceJet Turnaround

SpiceJet Turnaround

SpiceJet board approves up to $243 mln share sale plan  Full Article 

Currency Market

Currency Market

RBI urges companies to hedge FX exposure  Full Article 

Uber's Woes

Uber's Woes

Delhi Uber passenger who alleges driver rape sues in U.S.  Full Article 

Banking Sector

Banking Sector

Banks say no room to cut lending rates, thwarting RBI easing  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage